Research Article
Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
Table 4
Multivariate analysis for prognostic indicators in MM.
| | Surgical | Cytology | HR | | HR | |
| Age | | | | | ≤74 | 1.0 (ref) | | 1.0 (ref) | | >74 | 1.369 | 0.214 | 1.778 | 0.070 | Sex | | | | | Female | 1.0 (ref) | | 1.0 (ref) | | Male | 1.3 | 0.376 | 1.701 | 0.378 | Subtype | | | | | Epithelioid | 1.0 (ref) | | 1.0 (ref) | | Biphasic | 2.565 | 0.081 | 2.585 | 0.052 | Sarcomatoid | 1.745 | 0.013 | 3.156 | 0.015 | BAP1 status | | | | | <50% | 2.226 | 0.003 | 1.882 | 0.047 | >50% | 1.0 (ref) | | 1.0 (ref) | |
|
|